XtalPi
Zhixiong Lin is currently the Director of R&D in drug discovery at XtalPi Inc. Previously, Zhixiong was the Senior Investigator of Computational Chemistry at Silicon Therapeutics and the Senior Scientist & Head of Computational Group at Adagene. Zhixiong also worked as a Post-doc on Computational Chemistry at ETH Zurich. Zhixiong holds a PhD in Computational Biology from the University of Science and Technology of China, where they also obtained a Bachelor's degree in Biology.
This person is not in any offices
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.